CEO
Successful builder of multiple cell therapy companies including allogeneic T-cell, NK cell and γ𝛅T cell platforms.
Read more
CSO
Pioneer in cell therapy development with leadership roles at Century Therapeutics, Metagenomi, and Five Prime Therapeutics, advancing multiple programs to the clinic.
Read more
.avif)
CMO
Clinical innovator in immunotherapy and oncology, former CMO at TriSalus Life Sciences, leading multiple drug-device combination clinical trial programs.
Read more
Co-founder, Head of Japan Operations
Experienced leader in biotech company creation and venture capital, specializing in the Japanese biotech ecosystem.
Co-founder, Head of Discovery Japan
Global executive with extensive leadership in Japanese startups and R&D across the U.S. and Japan.
VP, Discovery and US site head
Innovative translational scientist with deep expertise in cell & gene therapy, viral vectors, and process development.
.avif)
VP, Head of HR and US Operations
Management leader with 20+ years’ experience across biotech, high-tech, and healthcare industries, focused on building cultures of innovation and collaboration.
.avif)
VP, Head of CMC & Manufacturing
Expert in CMC development with over 15 years’ experience, leading clinical manufacturing and INDs for both autologous and allogeneic cell therapies.
.avif)
VP, Head of Program Leadership & Management
Seasoned leader in global pharmaceutical development, previously Global Program Leader at Takeda, successfully advancing three cell therapy programs into clinical trials.
.avif)
Renowned CAR-T therapy pioneer and Director of the Center for Cellular Immunotherapies at the University of Pennsylvania.
.avif)
Global authority in autoimmune research, Chair of Internal Medicine at Friedrich-Alexander-Universität Erlangen-Nürnberg, and innovator in CAR-T therapies for autoimmune diseases.
.avif)
Leading expert in CAR-NK cell immunotherapy and Chair of Stem Cell Transplantation and Cellular Therapy at MD Anderson Cancer Center.
Scientific Co-Founder
Pioneer of iPS-T cell research and Deputy Director at the Center for iPS Cell Research and Application (CiRA) at Kyoto University.
Scientific Co-Founder
World-renowned leader in immune evasion technology and transplant surgeon at UCSF.
F-Prime Capital
USA
Partner, and co-founding investor in Shinobi Therapeutics
Eight Roads Ventures Japan
Japan
Partner, and co-founding investor in Shinobi Therapeutics
EQT Life Sciences
USA
Partner, and lead investor of Series A round in late 2023
Shinobi Therapeutics
USA
CEO of Shinobi Therapeutics
Shinobi Therapeutics
Japan
Co-founder of Shinobi Therapeutics
Kyoto University
Japan
Professor at Kyoto University, and scientific co-founder of Shinobi Therapeutics
.avif)
Shinobi’s international presence merges the best of global innovation, with advanced iPSC research and streamlined clinical infrastructure rooted in Japan paired with cutting-edge biotechnology and genetic engineering in the U.S., to bring us the next generation of cell therapies.
